Oita University Hospital

Yufu 879-5593

2 studies enrolling now · 4 studies all time

What they study most

Alzheimer Disease, Amyloid, Atrial Fibrillation, Cognitive Dysfunction, Lewy Body Disease, Parkinson Disease, Synucleinopathies

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Recruiting now
• A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease — Recruiting now
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling